Pleiotrophin induces angiogenesis: Involvement of the phosphoinositide-3 kinase but not the nitric oxide synthase pathways
Authors:
- 6 February 2001
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 187 (1) , 59-64
Abstract
Pleiotrophin (PTN) is a developmentally regulated protein that has been shown to be involved in tumor growth and metastasis presumably by activating tumor angiogenesis. To clarify the potential angiogenic activity of PTN and to analyze the signaling pathways involved in this process, we used an in vitro model of Human Umbilical Vein Endothelial Cells (HUVEC). We show that PTN was mitogenic toward a variety of endothelial cells including HUVEC, stimulated HUVEC migration across a reconstituted basement membrane and induced the formation of capillary‐like structures by HUVEC grown as 3D‐cultures in Matrigel or collagen. The signaling pathways triggered following endothelial cell stimulation by PTN were studied by using pharmacological inhibitors of the Phosphoinositide‐3 kinase (PI3K) and endothelial Nitric Oxide Synthase (eNOS), two enzymes that have been shown to be crucial in the angiogenic response to Vascular Endothelial Growth Factor (VEGF). Whereas wortmannin (a PI3K inhibitor) and L‐NAME (an eNOS inhibitor) dramatically reduced HUVEC growth induced by VEGF, only the former inhibitor reduced the growth induced by PTN and to a lesser extent that stimulated by basic Fibroblast Growth Factor. Thus, our results indicate that PTN induces angiogenesis and utilizes PI3K‐ but not eNOS‐dependent pathways for its angiogenic activity.Keywords
This publication has 27 references indexed in Scilit:
- Regulation of endothelium-derived nitric oxide production by the protein kinase AktNature, 1999
- Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylationNature, 1999
- HB-GAM/Pleiotrophin but Not RIHB/Midkine Enhances Chondrogenesis in Micromass CultureExperimental Cell Research, 1998
- Angiogenesis as a Target for Tumor TreatmentOncology, 1997
- Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophinProceedings of the National Academy of Sciences, 1996
- Fighting Cancer by Attacking its Blood SupplyScientific American, 1996
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995
- Pleiotrophin transforms NIH 3T3 cells and induces tumors in nude mice.Proceedings of the National Academy of Sciences, 1993
- The Fgf Family of Growth Factors and Oncogenes1992
- Mitogenic properties of a new endothelial cell growth factor related to pleiotrophinBiochemical and Biophysical Research Communications, 1991